These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 35915937

  • 21. BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival.
    Bahnasy AA, El-Din RS, Sabri NA, Abdel-Rahman CA, Bastawisy AE.
    Cancer Genet; 2018 Dec; 228-229():83-92. PubMed ID: 30553477
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
    Alì G, Borrelli N, Riccardo G, Proietti A, Pelliccioni S, Niccoli C, Boldrini L, Lucchi M, Mussi A, Fontanini G.
    J Thorac Oncol; 2013 Nov; 8(11):1389-95. PubMed ID: 24084442
    [Abstract] [Full Text] [Related]

  • 24. Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma.
    Patil NS, Righi L, Koeppen H, Zou W, Izzo S, Grosso F, Libener R, Loiacono M, Monica V, Buttigliero C, Novello S, Hegde PS, Papotti M, Kowanetz M, Scagliotti GV.
    J Thorac Oncol; 2018 Jan; 13(1):124-133. PubMed ID: 29079455
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IL-7 is expressed in malignant mesothelioma and has a prognostic value.
    Mai HL, Deshayes S, Nguyen TV, Dehame V, Chéné AL, Brouard S, Blanquart C.
    Mol Oncol; 2022 Oct; 16(20):3606-3619. PubMed ID: 36054746
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.
    Inaguma S, Lasota J, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Schrump DS, Hassan R, Kasai K, Miettinen M, Ikeda H.
    J Pathol; 2020 Feb; 250(2):205-216. PubMed ID: 31639216
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.
    Stockhammer P, Ploenes T, Theegarten D, Schuler M, Maier S, Aigner C, Hegedus B.
    Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960
    [Abstract] [Full Text] [Related]

  • 35. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
    Pasello G, Zago G, Lunardi F, Urso L, Kern I, Vlacic G, Grosso F, Mencoboni M, Ceresoli GL, Schiavon M, Pezzuto F, Pavan A, Vuljan SE, Del Bianco P, Conte P, Rea F, Calabrese F.
    Ann Oncol; 2018 May 01; 29(5):1258-1265. PubMed ID: 29514216
    [Abstract] [Full Text] [Related]

  • 36. Expression of Numb and Gli1 in malignant pleural mesothelioma and their clinical significance.
    Zhang C, Kang Y, Ma R, Chen F, Chen F, Dong X.
    J Cancer Res Ther; 2018 May 01; 14(5):970-976. PubMed ID: 30197333
    [Abstract] [Full Text] [Related]

  • 37. MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.
    Pasello G, Urso L, Mencoboni M, Grosso F, Ceresoli GL, Lunardi F, Vuljan SE, Bertorelle R, Sacchetto V, Ciminale V, Rea F, Favaretto A, Conte P, Calabrese F.
    Oncotarget; 2015 Dec 08; 6(39):42053-66. PubMed ID: 26544728
    [Abstract] [Full Text] [Related]

  • 38. The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
    Giroux Leprieur E, Hirata T, Mo M, Chen Z, Okamoto J, Clement G, Li H, Wislez M, Jablons DM, He B.
    Lung Cancer; 2014 Sep 08; 85(3):465-71. PubMed ID: 25023662
    [Abstract] [Full Text] [Related]

  • 39. POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma.
    Shimizu D, Ishibashi M, Yamada T, Toda Y, Hosogi S, Ashihara E.
    Cancer Genomics Proteomics; 2024 Sep 08; 21(2):158-165. PubMed ID: 38423601
    [Abstract] [Full Text] [Related]

  • 40. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
    Martínez-Rivera V, Negrete-García MC, Ávila-Moreno F, Ortiz-Quintero B.
    Int J Mol Sci; 2018 Feb 17; 19(2):. PubMed ID: 29462963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.